Combining in vivo and in vitro studies to elucidate the inhibitory effect of resveratrol on vorolanib metabolism

IntroductionVorolanib is a new-generation multi-targeted kinase inhibitor (MTKI) whose drug-drug interaction (DDI) profile remains largely unexplored. This study combined in vitro and in vivo approaches to systematically investigate the effect of resveratrol on vorolanib metabolism.MethodsUsing ultr...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Dongxin Chen, Hailun Xia, Lu Cao, Haoxin Fu, Yan Chen, Shiqi Jiang, Runjuan Zhan
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2026-05-01
Цуврал:	Frontiers in Pharmacology
Нөхцлүүд:	combination therapy drug-drug interactions pharmacokinetic resveratrol vorolanib
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fphar.2026.1819774/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!